Session 1: How are key gene delivery platforms stacking up both in vivo and ex vivo to address concerns around safety, immunogenicity, durability, efficacy, and redosing potential?

Advanced Therapies Week 2027 · 19 January 2027 · 11:00–12:00 · Theatre 3

Session 1: How are key gene delivery platforms stacking up both in vivo and ex vivo to address concerns around safety, immunogenicity, durability, efficacy, and redosing potential? was a session at Advanced Therapies Week 2027 on 19 January 2027 in San Diego, with 3 speakers on record.

Speakers

• Mark Kay — Speaker Dennis Farrey Family Professor, Departments of Pediatrics and Genetics; Head, Division of Human Gene Therapy, Stanford University
• Mercedes Segura Gally — Speaker VP Process Development, Editas Medicine
• Kate Excoffon — Speaker American Society for Gene and Cell Therapy, American Society of Gene & Cell Therapy